|
2024 Conference Publication Cellular Genomics of Bronchoalveolar Lavage Reveals Insight into Mechanisms of Human Pulmonary FibrosisZhang, L.-Y., Apte, S., Lutzky, V., Groves, P., Tan, M., de Silva, T.A., Nguyen, Q., Powell, J., Chambers, D. and O'Sullivan, B. (2024). Cellular Genomics of Bronchoalveolar Lavage Reveals Insight into Mechanisms of Human Pulmonary Fibrosis. American Thoracic Society 2024 International Conference, San Diego, CA United States, 17-22 May 2024. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2580 |
|
2023 Conference Publication Late Breaking Abstract - Transcriptomic profiling identifies pro-fibrotic macrophages under ferroptotic stress in silicosisAloe, Christian, Goh, Nicole Soo Leng, Mcqualter, Jonathan, Pujari, Reshma, Cameron, Rhoda, Teague, Julie, Papagianis, Paris, Apte, Simon Hall, O'Sullivan, Brendan, Vlahos, Ross, Mcdonald, Christine Faye, Hoy, Ryan Francis, Chambers, Daniel Charles, Leong, Tracy Li-Tsein and Bozinovski, Steven (2023). Late Breaking Abstract - Transcriptomic profiling identifies pro-fibrotic macrophages under ferroptotic stress in silicosis. Annual Congress of the European-Respiratory-Society (ERS), Milan Ia, Sep 09-13, 2023. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2023.PA2233 |
|
2022 Conference Publication Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemicMoore, , Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, , Grainge, C., Wilsher, M., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. (2022). Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemic. HOBOKEN: WILEY. |
|
2022 Conference Publication Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national populationChee, M., Corte, T., Jackson, D., Lee, C., Wrobel, J., Glaspole, , Grainge, C., Wilsher, M., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Thien, F. (2022). Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national population. HOBOKEN: WILEY. |
|
2022 Conference Publication Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaireBarnes, H., Chambers, D., Grainge, C., Corte, T., Bastiampillai, S., Frenkel, S., Westall, G., Collard, H. and Glaspole, (2022). Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaire. HOBOKEN: WILEY. |
|
2022 Conference Publication Polygenic risk scores in familial IPF implicates rare variantsLucas, S., Raspin, K., Chambers, D., Glaspole, , Reynolds, P., Schwartz, D., Walters, H., Wood-Baker, R., Walsh, S., Moodley, Y., Corte, T. and Dickinson, J. (2022). Polygenic risk scores in familial IPF implicates rare variants. HOBOKEN: WILEY. |
|
2021 Conference Publication The Performance of RA Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis-Associated Interstitial Lung Disease in a Prospective Trial Using Pirfenidone in RA ILD (TRAIL1)Dellaripa, Paul, Doyle, Tracy, Danoff, Sonye, Goldberg, Hillary, Kolb, Martin, Chambers, Daniel, Woodhead, Felix, Spino, Cathy, Rosas, Ivan and Solomon, Joshua (2021). The Performance of RA Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis-Associated Interstitial Lung Disease in a Prospective Trial Using Pirfenidone in RA ILD (TRAIL1). ACR Convergence Conference, Electr Network, Nov 05-09, 2021. HOBOKEN: WILEY. |
|
2021 Conference Publication A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung DiseaseSolomon, Joshua, Woodhead, Felix, Danoff, Sonye, Haynes-Harp, Shana, Naik, Tanvi, Spino, Cathie, Hurwitz, Shelley, Maurer, Rie, Chambers, Daniel, Kolb, Martin, Goldberg, Hiliary and Rosas, Ivan (2021). A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease. ACR Convergence Conference, Electr Network, Nov 05-09, 2021. HOBOKEN: WILEY. |
|
2020 Conference Publication A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung TransplantationDivithotawela, C., Pham, A., Ledger, E. L., Hopkins, P., Tan, M., Yerkovich, S., Wells, T. J. and Chambers, D. C. (2020). A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation. 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), Montreal, Canada, 22-25 April 2020. New York, NY United States: Elsevier. |
|
2019 Conference Publication Reconstruction of Transcriptional Programs of Monocyte to Macrophage Sequential Cell Fate Transition Using Single Cell RNA Sequencing in Sex Mis-Matched Lung TransplantationO'Sullivan, B., Powell, J., Lukowski, S., Tan, M., Hopkins, P. and Chambers, D. (2019). Reconstruction of Transcriptional Programs of Monocyte to Macrophage Sequential Cell Fate Transition Using Single Cell RNA Sequencing in Sex Mis-Matched Lung Transplantation. 39th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation (ISHLT), Orlando, FL, United States, 3-6 April 2019. Philadelphia, PA, United States: Elsevier . doi: 10.1016/j.healun.2019.01.375 |
|
2016 Conference Publication Human Lung-Derived Mesenchymal Stromal Cells Donate Cytoplasmic Content to Bronchial Epithelium Through Microtubules, Tunnelling Nanotubes, Gap Junctions and MicrovesiclesSinclair, K. A., Yerkovich, S., Hopkins, P. and Chambers, D. (2016). Human Lung-Derived Mesenchymal Stromal Cells Donate Cytoplasmic Content to Bronchial Epithelium Through Microtubules, Tunnelling Nanotubes, Gap Junctions and Microvesicles. 22nd Annual Scientific Meeting of the International Society for Cell Therapy (ISCT) , Singapore, May 2016. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jcyt.2016.03.034 |
|
2016 Conference Publication Mesenchymal Stromal Cells Isolated From Pulmonary Transplant Recipients by Bronchoalveolar Lavage Are ProfibroticSinclair, K., Yerkovich, S., Hopkins, P. and Chambers, D. (2016). Mesenchymal Stromal Cells Isolated From Pulmonary Transplant Recipients by Bronchoalveolar Lavage Are Profibrotic. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting, Perth, Western Australia, 1–6 April 2016. Malden MA United States: Wiley-Blackwell. |
|
2015 Conference Publication Transbronchial Brush (Tbbr) Reliably Quantifies Lymphocytic Bronchiolitis and Predicts Subsequent Chronic Lung Allograft DysfunctionYerkovich, S., Samson, L., Sinclair, K., Tan, M., Gallagher, H., Fiene, A., Hopkins, P. and Chambers, D. (2015). Transbronchial Brush (Tbbr) Reliably Quantifies Lymphocytic Bronchiolitis and Predicts Subsequent Chronic Lung Allograft Dysfunction. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell. |
|
2015 Conference Publication Adoptive T-Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cmv Disease After Lung TransplantationHolmes-Liew, C., Holmes, M., Beagley, L., Hopkins, P., Chambers, D., Smith, C. and Khanna, R. (2015). Adoptive T-Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cmv Disease After Lung Transplantation. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell. |
|
2015 Conference Publication Hyaluronan - the First New Biomarker of Donor Organ Quality Since Po2?Sladden, T., Samson, L., Hopkins, P., Yerkovich, S. and Chambers, D. (2015). Hyaluronan - the First New Biomarker of Donor Organ Quality Since Po2?. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell. |
|
2015 Conference Publication Prevalence of actinic keratosis and the risk factors for skin cancer in lung transplant recipients in Queensland, AustraliaSahebian, A., Morze, C., Grant, M., Hopkins, P., Yerkovich, S., Chambers, D. and Soyer, H. P. (2015). Prevalence of actinic keratosis and the risk factors for skin cancer in lung transplant recipients in Queensland, Australia. 48th Annual Scientific Meeting of the Australasian College of Dermatologists, Adelaide SA, Australia, 16 May 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337 |
|
2015 Conference Publication Effects of Human Rhinovirus Infection in Large and Small Airway of Lung Transplant RecipientsLing, K., Lavendar, M., Musk, M., Wrobel, J., Garratt, L., Martinovich, K., Shaw, N., Iosifidis, T., Looi, K., Kicic-Starcevich, E., Lannigan, F., Hopkins, P., Chambers, D., Sutanto, E., Stick, S. and Kicic, A. (2015). Effects of Human Rhinovirus Infection in Large and Small Airway of Lung Transplant Recipients. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell. |
|
2015 Conference Publication Physical Activity Level - a New Marker of Frailty in Lung TransplantationWalsh, J., Chambers, D., Yerkovich, S., Hopkins, P. and Morris, N. (2015). Physical Activity Level - a New Marker of Frailty in Lung Transplantation. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Queensland, Australia, 27 March–1 April 2015. Malden MA United States: Wiley-Blackwell. |
|
2014 Conference Publication DYSREGULATED REPAIR AND EPITHELIAL INJURY IN SMALL AND LARGE AIRWAYS OF LUNG TRANSPLANT PATIENTS IS AMELIORATED BY AZITHROMYCINKicic, A., Lavender, M., Musk, M., Wrobel, J., Banerjee, B., Ling, K., Martinovich, K., Garratt, L., Iosifidis, T., Looi, K., Kicic-Starvevich, E., Lannigan, F., Hopkins, P., Yerkovich, S., Sutanto, E., Chambers, D. and Stick, S. (2014). DYSREGULATED REPAIR AND EPITHELIAL INJURY IN SMALL AND LARGE AIRWAYS OF LUNG TRANSPLANT PATIENTS IS AMELIORATED BY AZITHROMYCIN. HOBOKEN: WILEY-BLACKWELL. doi: 10.1111/resp.12264 |
|
2014 Conference Publication A Phase 1B Study of Mesenchymal Stromal Cell Therapy for Idiopathic Pulmonary FibrosisChambers, D. C., Enever, D., Ilic, N., Sparks, L., Ayres, J., Yerkovich, S. T., Khalil, D., Atkinson, K. and Hopkins, P. M. (2014). A Phase 1B Study of Mesenchymal Stromal Cell Therapy for Idiopathic Pulmonary Fibrosis. ISCT 2014 Annual Meeting, Paris France, April 23-26 2014. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jcyt.2014.01.029 |
